Article
Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development.
Thorax - 1 Nov 2017
Milger Katrin, Yu Yingyan, Brudy Eva, Irmler Martin, Skapenko Alla, Mayinger Michael, Lehmann Mareike, Beckers Johannes, Reichenberger Frank, Behr Jürgen, Eickelberg Oliver, Königshoff Melanie, Krauss-Etschmann Susanne
Abstract excerpt
BACKGROUND: Animal models have suggested that CCR2-dependent signalling contributes to the pathogenesis of pulmonary fibrosis, but global blockade of CCL2 failed to improve the clinical course of patients with lung fibrosis. However, as levels of CCR2+CD4+ T cells in paediatric lung fibrosis had previously been found to be increased, correlating with clinical symptoms, we hypothesised that distinct CCR2+ cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
